Log In
Print this Print this

XOMA 213 (formerly LFA102)

  Manage Alerts
Collapse Summary General Information
Company Xoma Corp.
DescriptionHuman IgG1 kappa mAb against prolactin receptor (PRLR)
Molecular Target Prolactin receptor (PRLR)
Mechanism of ActionProlactin receptor (PRLR) antagonist
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard Indication Endocrine (unspecified)
Indication DetailsSuppress lactation immediately postpartum
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today